FOXO TECHNOLOGIES INC-CL A (FOXO) Stock Overview
USA - NYSEARCA:FOXO - US3514713052 - Common Stock
FOXO Key Statistics, Chart & Performance
The current stock price of FOXO is 0.0922 USD. In the past month the price decreased by -67.37%. In the past year, price decreased by -96.68%.
FOXO Latest News, Press Relases and Analysis
FOXO Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| PLTR | PALANTIR TECHNOLOGIES INC-A | 356.94 | 448.61B | ||
| SAP | SAP SE-SPONSORED ADR | 39.33 | 315.78B | ||
| CRM | SALESFORCE INC | 23.92 | 243.21B | ||
| APP | APPLOVIN CORP-CLASS A | 84.73 | 217.53B | ||
| INTU | INTUIT INC | 33.8 | 190.54B | ||
| ADBE | ADOBE INC | 17.66 | 149.78B | ||
| CDNS | CADENCE DESIGN SYS INC | 52.14 | 95.75B | ||
| SNPS | SYNOPSYS INC | 34.5 | 86.45B | ||
| MSTR | STRATEGY INC | 8.66 | 84.88B | ||
| ADSK | AUTODESK INC | 33.46 | 66.78B | ||
| WDAY | WORKDAY INC-CLASS A | 28.96 | 63.79B | ||
| DDOG | DATADOG INC - CLASS A | 84.29 | 54.97B |
Related stock screener links
About FOXO
Company Profile
FOXO Technologies, Inc. develops genetic sequencing technology, artificial intelligence and bioinformatics tools. The company is headquartered in Minneapolis, Minnesota. The company went IPO on 2020-12-11. The firm owns and operates three subsidiaries: Foxo Labs, Inc., Myrtle Recovery Centers, Inc., and Rennova Community Health, Inc. The company applies automated machine learning and artificial intelligence (AI) technologies to discover epigenetic biomarkers of human health, wellness and aging. Its segments include Healthcare and Labs and Life. The Healthcare segment offers behavioral health services, including substance abuse treatment. Services are provided on either an inpatient, residential basis or an outpatient basis. The company offers alcohol and drug residential detoxification and residential rehabilitation treatment services for up to 30 patients. The Labs and Life segment is commercializing proprietary epigenetic biomarker technology to be used for underwriting risk classification in the global life insurance industry.
Company Info
FOXO TECHNOLOGIES INC-CL A
729 Washington Ave. N, Suite 600
Minneapolis MINNESOTA US
Employees: 135
Phone: 16125629447
FOXO TECHNOLOGIES INC-CL A / FOXO FAQ
What does FOXO TECHNOLOGIES INC-CL A do?
FOXO Technologies, Inc. develops genetic sequencing technology, artificial intelligence and bioinformatics tools. The company is headquartered in Minneapolis, Minnesota. The company went IPO on 2020-12-11. The firm owns and operates three subsidiaries: Foxo Labs, Inc., Myrtle Recovery Centers, Inc., and Rennova Community Health, Inc. The company applies automated machine learning and artificial intelligence (AI) technologies to discover epigenetic biomarkers of human health, wellness and aging. Its segments include Healthcare and Labs and Life. The Healthcare segment offers behavioral health services, including substance abuse treatment. Services are provided on either an inpatient, residential basis or an outpatient basis. The company offers alcohol and drug residential detoxification and residential rehabilitation treatment services for up to 30 patients. The Labs and Life segment is commercializing proprietary epigenetic biomarker technology to be used for underwriting risk classification in the global life insurance industry.
Can you provide the latest stock price for FOXO TECHNOLOGIES INC-CL A?
The current stock price of FOXO is 0.0922 USD. The price decreased by -9.96% in the last trading session.
Does FOXO TECHNOLOGIES INC-CL A pay dividends?
FOXO does not pay a dividend.
What is the ChartMill rating of FOXO TECHNOLOGIES INC-CL A stock?
FOXO has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
What is the GICS sector and industry of FOXO stock?
FOXO TECHNOLOGIES INC-CL A (FOXO) operates in the Information Technology sector and the Software industry.
What is FOXO TECHNOLOGIES INC-CL A worth?
FOXO TECHNOLOGIES INC-CL A (FOXO) has a market capitalization of 492.35K USD. This makes FOXO a Nano Cap stock.
When does FOXO TECHNOLOGIES INC-CL A (FOXO) report earnings?
FOXO TECHNOLOGIES INC-CL A (FOXO) will report earnings on 2025-11-17.
FOXO Technical Analysis
FOXO Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to FOXO. FOXO may be in some trouble as it scores bad on both profitability and health.
FOXO Financial Highlights
Over the last trailing twelve months FOXO reported a non-GAAP Earnings per Share(EPS) of -20.41. The EPS increased by 84.44% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -29.86% | ||
| ROE | -128.8% | ||
| Debt/Equity | 0.62 |